MediBeacon® Transdermal GFR System is a first-in-kind product for point of care kidney function assessmentCenters of Excellence commercialization in select academic medical centers began in January 2026 NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that MediBeacon Inc. (“MediBeacon”), a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, in which INNOVATE owns a 44.7% ...

INNOVATE Corp. Q3 2025 Earnings Release Supplement November 12, 2025 INNOVATE Corp. 2025 Safe Harbor Disclaimers Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains, and certain oral statements made by our representatives from time to time may contain, "forward-looking statements." Generally, forward-looking statements include information describing actions, events, results, strategies and expe ...

Core Insights - Protiviti has appointed Amy Wilkinson to its advisory board, effective September 1, 2025, to enhance its expertise in AI-enabled business models and provide strategic guidance [1][5]. Group 1: Appointment and Expertise - Amy Wilkinson is the founder and CEO of Ingenuity and a faculty member at Stanford Graduate School of Business, bringing extensive expertise in innovation and AI-enabled business models that drive growth [2]. - Wilkinson has a robust background in corporate strategy, private equity, and startups, having collaborated with major organizations like Google, Salesforce, and Roche [3]. - She has served as an Independent Director for Hut 8 and Innovate, showcasing her business judgment and financial acumen [4]. Group 2: Strategic Importance - Joseph Tarantino, president and CEO of Protiviti, emphasized that Wilkinson's depth of experience and forward-looking perspective will provide valuable insights to the advisory board and clients [5]. - Wilkinson expressed enthusiasm about contributing to Protiviti's mission and collaborating with its management team, particularly in the areas of AI and innovation [6]. Group 3: Company Overview - Protiviti is a global consulting firm with over 90 offices in more than 25 countries, providing consulting and managed solutions across various sectors [7]. - The firm has been recognized on the Fortune 100 Best Companies to Work For® list for 11 consecutive years and serves over 80% of Fortune 100 and nearly 80% of Fortune 500 companies [8].

Financial Performance - INNOVATE Corp's Q2 2025 consolidated revenue was $242 million[16], a decrease of $71.1 million or 22.7% compared to Q2 2024[21] - The company reported a net loss attributable to INNOVATE Corp of $198 million in Q2 2025[17] - Adjusted EBITDA for Q2 2025 was $157 million[20], a decrease of $11 million compared to Q2 2024[21] Segment Performance - Infrastructure (DBMG) - Infrastructure segment revenue decreased to $2331 million in Q2 2025 from $3052 million in Q2 2024[16], a 236% decrease[25] - Infrastructure segment's adjusted EBITDA decreased by $132 million year-over-year[21] to $193 million[17] - DBMG's adjusted backlog remained strong at $13 billion in Q2 2025[12] Segment Performance - Life Sciences (R2 Technologies) - Life Sciences segment revenue increased to $32 million in Q2 2025 from $17 million in Q2 2024[16], an 882% increase[12, 21] - R2 Technologies experienced gross system unit sales growth of 1245% over the prior year quarter worldwide[30] Segment Performance - Spectrum - Spectrum segment revenue decreased to $57 million in Q2 2025 from $62 million in Q2 2024[16] - Spectrum segment reported adjusted EBITDA of $10 million in Q2 2025[12, 17] Debt and Refinancing - On August 4, 2025, INNOVATE closed a series of indebtedness refinancing transactions[12] - Total principal outstanding debt as of June 2025 was $6413 million[35]

Core Viewpoint - INNOVATE Corp. announced that its subsidiary DBM Global Inc. will pay a cash dividend of approximately $4.4 million, or $1.14 per share, to its stockholders on August 21, 2025, with INNOVATE expected to receive around $4 million of this payout [1] Company Overview - INNOVATE Corp. operates a portfolio of assets in three key areas: Infrastructure, Life Sciences, and Spectrum, employing approximately 3,100 people across its subsidiaries [2] - DBM Global Inc. specializes in integrated steel construction services and offers a range of professional services including design-assist, engineering, and project management, serving various market segments such as commercial, healthcare, and public works [3]

Core Points - DBM Global Inc. will pay a cash dividend of approximately $5.5 million, or $1.42 per share, on June 16, 2025, to stockholders of record as of June 2, 2025 [1] - DBM Global Inc. is a family of companies providing fully integrated steel construction services and is an operating subsidiary of INNOVATE Corp. [1][2] Company Overview - DBM Global Inc. focuses on delivering sustainable value through a collaborative portfolio of companies that offer better designs, efficient construction, and superior asset management solutions [2] - The company provides integrated steel construction services, including design-assist, design-build, engineering, detailing, BIM coordination, steel modeling/detailing, fabrication, rebar detailing, advanced field erection, project management, and steel management systems [2] - Major market segments for DBM Global Inc. include commercial, healthcare, convention centers, stadiums, gaming and hospitality, mixed-use and retail, industrial, public works, bridges, transportation, and international projects [2] - The company is headquartered in Phoenix, Arizona, and has operations in the United States, Australia, Canada, India, New Zealand, the Philippines, and the United Kingdom [2]

Group 1 - DBM Global Inc. has entered into an amended and restated credit agreement providing for an $85 million term loan and a $135 million revolving credit facility, aimed at repaying existing debt and enhancing working capital capacity [1][2] - The total amount of the Credit Facility is $220 million, maturing on May 20, 2030, with an accordion feature allowing an increase of up to $50 million [2] - The CEO of DBMG expressed enthusiasm about the relationship with banking partners and highlighted the liquidity support for the company's working capital needs [3] Group 2 - DBM Global Inc. focuses on delivering sustainable value through a collaborative portfolio of companies, offering integrated steel construction services and professional services across various market segments [4] - The company operates in multiple countries, including the United States, Australia, Canada, India, New Zealand, the Philippines, and the United Kingdom [4]

Financial Performance - Consolidated INNOVATE reported Q1 2025 revenue of $274.2 million, a decrease of $41.0 million or 13% compared to $315.2 million in Q1 2024[17, 22] - Net loss attributable to INNOVATE Corp was $24.5 million in Q1 2025[18, 22, 41] - Adjusted EBITDA decreased by $5.6 million to $7.2 million in Q1 2025, compared to $12.8 million in Q1 2024[18, 22] Segment Highlights - Infrastructure (DBMG) - Infrastructure segment revenue decreased to $264.9 million in Q1 2025 from $307.9 million in Q1 2024, a 14% decrease[17, 25, 27] - Infrastructure segment Adjusted EBITDA decreased to $16.7 million in Q1 2025 from $18.3 million in Q1 2024[18, 25, 27] - DBMG's adjusted backlog ended the first quarter with $1.4 billion, including over $500 million in new awards[12, 15, 27] Segment Highlights - Life Sciences (R2 Technologies) - Life Sciences segment revenue increased to $3.1 million in Q1 2025 from $1.0 million in Q1 2024, a 210% increase[17, 22] - R2 Technologies experienced gross system unit sales growth of 109% over the prior year quarter in North America and 163% worldwide[32] Segment Highlights - Spectrum - Spectrum segment revenue was $6.2 million in Q1 2025, compared to $6.3 million in Q1 2024[17, 33] - Spectrum segment Adjusted EBITDA was $1.4 million in Q1 2025, compared to $1.6 million in Q1 2024[12, 18, 33] Debt - Total principal outstanding debt was $672.0 million as of March 2025[36]

Core Insights - INNOVATE Corp. reported a consolidated revenue of $236.6 million for Q4 2024, a decrease of 34.5% compared to $361.0 million in Q4 2023, primarily driven by the Infrastructure segment [2][8] - The company experienced a net loss attributable to common stockholders of $16.9 million, or $1.29 per share, compared to a loss of $9.6 million, or $1.22 per share, in the prior year quarter [2][11] - The Infrastructure segment's revenue decreased to $225.7 million, down 36.2% from $353.8 million in the prior year quarter, while the Life Sciences and Spectrum segments showed growth [4][11] Financial Summary - Total Adjusted EBITDA for Q4 2024 was $15.0 million, down from $21.5 million in Q4 2023, reflecting challenges in the Infrastructure segment [14][15] - The company reduced its total debt by $54.5 million year-over-year, indicating improved financial health [3] Segment Performance Infrastructure - DBM Global's revenue for Q4 2024 was $225.7 million, a decrease of 36.2% year-over-year, with an adjusted backlog of $1.1 billion as of December 31, 2024 [4][5] - Gross margin improved to 18.2%, an increase of approximately 180 basis points year-over-year, despite a decrease in Adjusted EBITDA margin [4] Life Sciences - MediBeacon's TGFR system received FDA approval in January 2025, marking a significant milestone for the Life Sciences segment [10] - R2 Technologies reported a 113% increase in worldwide system unit sales in Q4 2024 compared to Q4 2023 [10] Spectrum - Broadcasting segment achieved double-digit revenue growth in Q4 2024, with revenue of $6.8 million compared to $5.7 million in the prior year quarter [10][11] Operational Highlights - The company announced collaborations in the Life Sciences segment with Woodhouse Spas and leading skincare brands, indicating strong market momentum [3] - Successful new network launches in the Spectrum segment contributed to revenue growth, despite some terminations of smaller networks [10]